Company Overview of APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. engages in the development of cyclosporine inhalation solution for the prevention of chronic rejection in lung transplantation. Its cyclosporine inhalation solution is an inhaled formulation of cyclosporine A, an oral medication is used to prevent rejection in solid organ transplant recipients. The company was founded in 1999 and is based in Burlingame, California.
700 Airport Boulevard
Burlingame, CA 94010
Founded in 1999
Key Executives for APT Pharmaceuticals, Inc.
Similar Private Companies By Industry
|PPD Development, LP||United States|
|Precision Vascular Systems, Inc.||United States|
|HyClone Laboratories, Inc.||United States|
|Trutek Corp.||United States|
|Insmed Therapeutic Proteins, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- Princeton, NJ | RGPPosted: Nov 27
- Parsippany, NJ | RGPPosted: Oct 21
- Remote, OR | ForestPosted: Dec 11
Sponsored Financial Commentaries
To contact APT Pharmaceuticals, Inc., please visit www.aptbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.